Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Endocrinology ; 158(8): 2441-2452, 2017 08 01.
Article in English | MEDLINE | ID: mdl-28637315

ABSTRACT

Prenatal undernutrition and low birth weight are associated with risk of type 2 diabetes and obesity. Prenatal caloric restriction results in low birth weight, glucose intolerance, obesity, and reduced plasma bile acids (BAs) in offspring mice. Because BAs can regulate systemic metabolism and glucose homeostasis, we hypothesized that BA supplementation could prevent diet-induced obesity and glucose intolerance in this model of developmental programming. Pregnant dams were food restricted by 50% from gestational days 12.5 to 18.5. Offspring of both undernourished (UN) and control (C) dams given unrestricted diets were weaned to high-fat diets with or without supplementation with 0.25% w/w ursodeoxycholic acid (UDCA), yielding four experimental groups: C, UN, C + UDCA, and UN + UDCA. Glucose homeostasis, BA composition, liver and intestinal gene expression, and microbiota composition were analyzed in the four groups. Although UDCA supplementation ameliorated diet-induced obesity in C mice, there was no effect in UN mice. UDCA similarly lowered fasting insulin, and improved glucose tolerance, pyruvate tolerance, and liver steatosis in C, but not UN, animals. BA composition differed significantly, and liver and ileal expression of genes involved in BA metabolism (Cyp7b1, Shp) were differentially induced by UDCA in C vs UN animals. Bacterial taxa in fecal microbiota correlated with treatment groups and metabolic parameters. In conclusion, prenatal undernutrition alters responsiveness to the metabolic benefits of BA supplementation, with resistance to the weight-lowering and insulin-sensitizing effects of UDCA supplementation. Our findings suggest that BA metabolism may be a previously unrecognized contributor to developmentally programmed diabetes risk.


Subject(s)
Bile Acids and Salts/pharmacology , Glucose/metabolism , Insulin Resistance/physiology , Malnutrition , Prenatal Nutritional Physiological Phenomena , Animals , Bile Acids and Salts/blood , Bile Acids and Salts/chemistry , Blood Glucose , Diet, High-Fat , Female , Male , Mice , Mice, Inbred ICR , Pregnancy , Prenatal Exposure Delayed Effects , Ursodeoxycholic Acid/administration & dosage , Ursodeoxycholic Acid/pharmacology
2.
Mol Metab ; 5(10): 926-936, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27689005

ABSTRACT

OBJECTIVE: Plasma levels of branched-chain amino acids (BCAA) are consistently elevated in obesity and type 2 diabetes (T2D) and can also prospectively predict T2D. However, the role of BCAA in the pathogenesis of insulin resistance and T2D remains unclear. METHODS: To identify pathways related to insulin resistance, we performed comprehensive gene expression and metabolomics analyses in skeletal muscle from 41 humans with normal glucose tolerance and 11 with T2D across a range of insulin sensitivity (SI, 0.49 to 14.28). We studied both cultured cells and mice heterozygous for the BCAA enzyme methylmalonyl-CoA mutase (Mut) and assessed the effects of altered BCAA flux on lipid and glucose homeostasis. RESULTS: Our data demonstrate perturbed BCAA metabolism and fatty acid oxidation in muscle from insulin resistant humans. Experimental alterations in BCAA flux in cultured cells similarly modulate fatty acid oxidation. Mut heterozygosity in mice alters muscle lipid metabolism in vivo, resulting in increased muscle triglyceride accumulation, increased plasma glucose, hyperinsulinemia, and increased body weight after high-fat feeding. CONCLUSIONS: Our data indicate that impaired muscle BCAA catabolism may contribute to the development of insulin resistance by perturbing both amino acid and fatty acid metabolism and suggest that targeting BCAA metabolism may hold promise for prevention or treatment of T2D.

3.
Article in English | MEDLINE | ID: mdl-27266599

ABSTRACT

BACKGROUND: Associating a patient's profile with the memories of prototypical patients built through previous repeat clinical experience is a key process in clinical judgment. We hypothesized that a similar process using a cognitive computing tool would be well suited for learning and recalling multidimensional attributes of speckle tracking echocardiography data sets derived from patients with known constrictive pericarditis and restrictive cardiomyopathy. METHODS AND RESULTS: Clinical and echocardiographic data of 50 patients with constrictive pericarditis and 44 with restrictive cardiomyopathy were used for developing an associative memory classifier-based machine-learning algorithm. The speckle tracking echocardiography data were normalized in reference to 47 controls with no structural heart disease, and the diagnostic area under the receiver operating characteristic curve of the associative memory classifier was evaluated for differentiating constrictive pericarditis from restrictive cardiomyopathy. Using only speckle tracking echocardiography variables, associative memory classifier achieved a diagnostic area under the curve of 89.2%, which improved to 96.2% with addition of 4 echocardiographic variables. In comparison, the area under the curve of early diastolic mitral annular velocity and left ventricular longitudinal strain were 82.1% and 63.7%, respectively. Furthermore, the associative memory classifier demonstrated greater accuracy and shorter learning curves than other machine-learning approaches, with accuracy asymptotically approaching 90% after a training fraction of 0.3 and remaining flat at higher training fractions. CONCLUSIONS: This study demonstrates feasibility of a cognitive machine-learning approach for learning and recalling patterns observed during echocardiographic evaluations. Incorporation of machine-learning algorithms in cardiac imaging may aid standardized assessments and support the quality of interpretations, particularly for novice readers with limited experience.


Subject(s)
Algorithms , Cardiomyopathy, Restrictive/diagnostic imaging , Decision Support Techniques , Echocardiography, Doppler/methods , Machine Learning , Pericarditis, Constrictive/diagnostic imaging , Aged , Area Under Curve , Biopsy , Cardiomyopathy, Restrictive/classification , Cardiomyopathy, Restrictive/physiopathology , Case-Control Studies , Diagnosis, Differential , Feasibility Studies , Female , Humans , Male , Middle Aged , Myocardium/pathology , Pericarditis, Constrictive/classification , Pericarditis, Constrictive/physiopathology , Pilot Projects , Predictive Value of Tests , ROC Curve , Reproducibility of Results , Stroke Volume , Ventricular Function, Left
4.
Diabetes ; 65(4): 902-12, 2016 04.
Article in English | MEDLINE | ID: mdl-26858359

ABSTRACT

Identifying markers of human insulin resistance may permit development of new approaches for treatment and prevention of type 2 diabetes. To this end, we analyzed the fasting plasma metabolome in metabolically characterized human volunteers across a spectrum of insulin resistance. We demonstrate that plasma betaine levels are reduced in insulin-resistant humans and correlate closely with insulin sensitivity. Moreover, betaine administration to mice with diet-induced obesity prevents the development of impaired glucose homeostasis, reduces hepatic lipid accumulation, increases white adipose oxidative capacity, and enhances whole-body energy expenditure. In parallel with these beneficial metabolic effects, betaine supplementation robustly increased hepatic and circulating fibroblast growth factor (Fgf)21 levels. Betaine administration failed to improve glucose homeostasis and liver fat content in Fgf21(-/-) mice, demonstrating that Fgf21 is necessary for betaine's beneficial effects. Together, these data indicate that dietary betaine increases Fgf21 levels to improve metabolic health in mice and suggest that betaine supplementation merits further investigation as a supplement for treatment or prevention of type 2 diabetes in humans.


Subject(s)
Betaine/pharmacology , Fibroblast Growth Factors/blood , Glucose/metabolism , Lipid Metabolism/drug effects , Liver/drug effects , Adult , Animals , Cells, Cultured , Dietary Supplements , Fatty Liver/chemically induced , Fatty Liver/drug therapy , Fatty Liver/genetics , Fatty Liver/metabolism , Female , Fibroblast Growth Factors/genetics , Glucose Intolerance/blood , Glucose Intolerance/drug therapy , Homeostasis/drug effects , Homeostasis/genetics , Humans , Liver/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Knockout
5.
Cell ; 137(4): 672-84, 2009 May 15.
Article in English | MEDLINE | ID: mdl-19450515

ABSTRACT

Chromosome segregation requires assembly of kinetochores on centromeric chromatin to mediate interactions with spindle microtubules and control cell-cycle progression. To elucidate the protein architecture of human kinetochores, we developed a two-color fluorescence light microscopy method that measures average label separation, Delta, at <5 nm accuracy. Delta analysis of 16 proteins representing core structural complexes spanning the centromeric chromatin-microtubule interface, when correlated with mechanical states of spindle-attached kinetochores, provided a nanometer-scale map of protein position and mechanical properties of protein linkages. Treatment with taxol, which suppresses microtubule dynamics and activates the spindle checkpoint, revealed a specific switch in kinetochore architecture. Cumulatively, Delta analysis revealed that compliant linkages are restricted to the proximity of chromatin, suggested a model for how the KMN (KNL1/Mis12 complex/Ndc80 complex) network provides microtubule attachment and generates pulling forces from depolymerization, and identified an intrakinetochore molecular switch that may function in controlling checkpoint activity.


Subject(s)
Kinetochores/chemistry , Kinetochores/metabolism , Microtubules/chemistry , Microtubules/metabolism , Cytoskeletal Proteins , DNA-Binding Proteins/metabolism , HeLa Cells , Humans , Metaphase , Microscopy, Fluorescence , Microtubule-Associated Proteins/metabolism , Nuclear Proteins
SELECTION OF CITATIONS
SEARCH DETAIL
...